Effects and Costs of a Day Care Centre Program Designed for People With Dementia (ECOD)
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT01943071 |
Recruitment Status :
Completed
First Posted : September 16, 2013
Last Update Posted : February 10, 2020
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
Condition or disease | Intervention/treatment | Phase |
---|---|---|
Dementia | Behavioral: Day care for patients with dementia | Not Applicable |
Study Type : | Interventional (Clinical Trial) |
Actual Enrollment : | 261 participants |
Allocation: | Non-Randomized |
Intervention Model: | Parallel Assignment |
Masking: | None (Open Label) |
Primary Purpose: | Health Services Research |
Official Title: | Effects and Costs of a Day Care Centre Program Designed for People With Dementia - a 24 Month Controlled Study |
Actual Study Start Date : | August 1, 2013 |
Actual Primary Completion Date : | December 1, 2017 |
Actual Study Completion Date : | December 31, 2017 |

Arm | Intervention/treatment |
---|---|
Experimental: Day care for patients with dementia
Day care for patients with dementia
|
Behavioral: Day care for patients with dementia
Day care centres designed by the local authorities for patients with dementia |
No Intervention: Care as usual
Care as usual
|
- Admittance to nursing home care [ Time Frame: 24 months ]The number of patients admitted to nursing home care during a period of 24 months will be the primary outcome for the effect and the cost-consequence analysis
- Change in Quality of life for patients [ Time Frame: 12 and 24 months ]The quality of life for patients as measured by Quality of Life - Alzheimer's Disease (QoL-AD)
- Change in the patient's functioning of daily living [ Time Frame: 12 and 24 months ]The Physical self-Maintenance Scale and Instrumental Activities of Daily Living Scale will be used to assess change in the patient's function of daily living
- Change in depressive symptoms in patients [ Time Frame: 12 and 24 months ]The change in depressive symptoms will be assessed by Montgomery Asberg Depression Rating Scale (MADRS)by interviews with both patient and family carer and the Cornell Scale for Depression in Dementia (CSDD) by interviews with family carers and a professional caregiver
- Change in patient's cognition [ Time Frame: 12 and 24 months ]Patient's cognition will be assessed using the Mini Mental State Examination (MMSE) the Clock Drawing Test (CDT), the Trail Making Test A (TMT-A)and the 10 word test of the Consortium to Establish a Registry in Alzheimer's Disease (CERAD)
- Change in neuropsychiatric symptoms in patients [ Time Frame: 12 and 24 months ]The change in Neuropsychiatric symptoms will be assessed using Neuropsychiatric Inventory Questionnaire (NPI-Q)
- Patients death [ Time Frame: 24 months ]Number of patients that have died during 24 months will be registered
- Change in level of burden in family carers [ Time Frame: 12 and 24 months ]Level of burden for family carers will be assessed by using the Relative's Stress Scale (RSS)
- Change in family carers depressive symptoms [ Time Frame: 12 and 24 months ]The MADRS will be used to assess depressive symptoms in family carers
- Change in quality of life for family carers [ Time Frame: 12 and 24 months ]QoL-AD will be used to assess quality of life in family carers
- Differences in the use of health resources between the intervention group and the control group [ Time Frame: 12 and 24 months ]The use of health resources will be measured using the resource Utilization in Dementia scale (RUD)
- Differences in quality adjusted life years between the intervention group and the control group [ Time Frame: 12 and 24 months ]A generic instrument, the EuroQol (EQ-5D) will be used to measure quality adjusted life years

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | 65 Years and older (Older Adult) |
Sexes Eligible for Study: | All |
Accepts Healthy Volunteers: | No |
Inclusion Criteria:
- Age of 65 years or more and living at home
- Patients in the day care centre group must have attended the centre for at least four weeks and have been there no longer than nine months
- Dementia of either Alzheimer's type, vascular dementia, dementia with Lewy bodies/Parkinson's disease or a mixture of these types of dementias
- Capacity to give informed consent as judged by the professional caregivers
- A Mini Mental Status Examination (MMSE) score of ≥15
- Having a family carer willing to participate, who see the patients personally at least once a week
- Attending the day care centre program at least twice a week
Exclusion Criteria:
- Having applied for nursing home placement
- Suffering from a serious co-morbid physical disorder with life expectancy less than six months

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01943071
Norway | |
Norwegian centre of Ageing and Health | |
Tønsberg, Norway, 3103 |
Study Chair: | Knut Engedal, Professor | Norwegian Centre for Ageling and health |
Responsible Party: | Norwegian Centre for Ageing and Health |
ClinicalTrials.gov Identifier: | NCT01943071 |
Other Study ID Numbers: |
NCAH-ECOD |
First Posted: | September 16, 2013 Key Record Dates |
Last Update Posted: | February 10, 2020 |
Last Verified: | February 2020 |
dementia day care centre programs patients family carers cost-consequence analysis |
Dementia Brain Diseases Central Nervous System Diseases |
Nervous System Diseases Neurocognitive Disorders Mental Disorders |